Saracatinib as a drug candidate for treatment of FOP edit

Saracatinib is currently tested for treatment of Fibrodysplasia Ossificans Progressiva (FOP), a rare muscoloskoletal disease. In regards of the current progress of clinical trials, it might be beneficial to include a chapter on FOP in this article.

https://cordis.europa.eu/project/id/821600/de https://classic.clinicaltrials.gov/ct2/show/NCT04307953 WiktorBurd (talk) 08:26, 29 July 2023 (UTC)Reply